Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector
Sort by: Date|Relevance

Analyst: G1 Minimizes the Carnage of Chemotherapy

ROTH Capital Partners initiates coverage on U.S. oncology biopharma G1 Therapeutics that is now filing an NDA. In a June 26 research note, analyst Tony Butler reported that ROTH Capital Partners initiated coverage on G1 Therapeutics Inc. (GTHX:NASDAQ) with a Buy ...
Streetwise Reports | July 2, 2020 |

'The Rock' Exploring for Copper and Silver in Canada

Gold is about to soar in price because of a worldwide misinformation campaign. So far the effects from the coronavirus are being mostly ignored by the markets. There seems to be hope that this virus will be contained or maybe it is denial of economic damage it will, and c...
Streetwise Reports | February 13, 2020 |

The Impossible Recession in the World’s Playground

Over the last six months, it has become very apparent that our global economy is changing. Yet most investors seem entirely complacent. FTD’s ™, aka Financially Transmitted Diseases , will start to appear and be used more frequently. And the policym...
Marin Katusa | September 6, 2019 |

Oil’s Crisis Spikes and the Impact on the Gold Price

At the time, the book was ground-breaking. Back in 2007, Nassim Taleb published a book called The Black Swan: The Impact of the Highly Improbable . He promoted not to try and speculate or predict wild, outlier type events… but to prepare and plan for them. The 20...
Marin Katusa | September 20, 2019 |

BioNTech, Evotec, XPhyto - will the next rally start?

Germany's leading index DAX closed the previous day at 11,391 points, its highest level since March 2020. At the beginning of the week the index of the 30 largest German companies gained 317 points compared to Friday, representing a gain of 2.87%. In the USA Wall Street remain...
Mario Hose | May 26, 2020 |

What’s Coming in Q4 – Adam (Fundamentalist) & Chris (Chartist) Explain

Recently I met an incredible trader and x-Bloomberg television anchor. His name is Adam Johnson and if you have not listened to his podcasts or followed his stock trading portfolio be sure to visit his website BullsEyeBrief.com Adam reached out to me a few weeks ago wa...
Chris Vermeulen | October 17, 2019 |

The New Cannabis & CBD Therapy for PTSD

This podcast is part of our StockTalk Cannabis Sector CEO interview series, and our mission going forward is to help listeners and investors understand more about investment opportunities in the public cannabis marketplace. There are around eight million people in the U...
Stockhouse Media | November 6, 2019 |

Yes, the Waterfall Selling in S&P 500 Is Over Now

Just as I called for, there wasn't much S&P 500 downside left, and I am hugely profitable on the upside reversal from near yesterday's premarket lows. That's quite a turn in momentum, isn't it? So, is the correction in the last throws? I would certainly say so in terms of ...
Monica Kingsley | June 16, 2020 |

Building a Better Covid-19 Antibody Test

ProMIS is harnessing its unique technology platform to develop a more error-free antibody test. Testing has been an Achilles heel of the coronavirus pandemic, but ProMIS Neurosciences Inc. (PMN:TSX; ARFXF:OTCQB) has partnered with Dr. Hans Frykman and the ...
Streetwise Reports | May 7, 2020 |

Palladium/Platinum Opportunity in Group Ten

A couple of weeks back I was calling for a correction in gold. All of a sudden everyone was talking about gold and how high it was going to go. Bullish sentiment hit an absurd extreme. I got it right; the correction began the next day. Investors tend to forget that ev...
Streetwise Reports | July 11, 2019 |
1 2 3 4 5 6 7 8 9 10 ...